Cancer research: from 'bench to bedside'

Chronic Myeloid Leukaemia (CML) is a rare blood cancer. Around 300 Australians are diagnosed with CML each year.

Personalised medicine

Dr Laura Eadie and her colleagues have been working on a test to identify which patients are most likely to respond poorly to traditional CML treatments.

The aim of this research? To ensure that when a patient is diagnosed with CML, a doctor will be able to run a test that will identify the patient as someone who falls into a higher risk group. This will help shape the treatment strategy for each patient, and ensure they are receiving the best medication to suit their cancer - this is personalised medicine.

Acknowledgments

Dr Eadie's PhD was supported by the Leukaemia Foundation of Australia. SAHMRI's Cancer Theme is supported with funding from the Cancer Council's Beat Cancer Project.

Get in touch

+61 8 8128 4000
hello@sahmri.com

You can't miss us

North Terrace
Adelaide 5000
South Australia

Postal address

PO Box 11060
Adelaide 5001
South Australia

Connect

Key partners

SAHMRI is located on the traditional lands of the Kaurna people.

The SAHMRI community acknowledges and pays respect to the Kaurna people as the traditional custodians of the Adelaide region. We also acknowledge the deep feelings of attachment and the relationship of the Kaurna people to their country. We pay our respects to the Kaurna peoples' ancestors and the living Kaurna people today.